Search Results - "Lv, Tangfeng"

Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice.

Authors: Lv, Tangfeng Zhao, Qi Liu, Jia et al.

Source: Infection. Apr2024, Vol. 52 Issue 2, p625-636. 12p.

Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.

Authors: Zou, Jiawei Lv, Tangfeng Zhu, Suhua et al.

Source: Thoracic Cancer. May2017, Vol. 8 Issue 3, p260-270. 11p.

A Narrative Review: The Role of NETs in Acute Respiratory Distress Syndrome/Acute Lung Injury.

Authors: Zhou, Xinyu Jin, Jiajia Lv, Tangfeng et al.

Source: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1464. 20p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Brain Metastatic Tumor Flare After Sunvozertinib Dose Reduction in a Patient with Surgical Resected EGFR ex20ins NSCLC.

Authors: Yan, Wenjie Yang, Nan Wang, Guoxin et al.

Source: OncoTargets & Therapy. Dec2025, Vol. 18, p1347-1352. 6p.

VISTA expressed on tumor cells is regulated by m6A and influences immune microenvironment through STAT3/CCL22 in NSCLC.

Authors: Xu, Hao Shen, Kaikai Jiang, Bei et al.

Source: Journal of Translational Medicine. 10/2/2025, Vol. 23 Issue 1, p1-18. 18p.

This result is not displayed to guests.
Login for full access.

The biology, function and clinical implications of exosomes in lung cancer.

Authors: Zhou, Li Lv, Tangfeng Zhang, Qun et al.

Source: Cancer Letters. Oct2017, Vol. 407, p84-92. 9p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC.

Authors: Shen, Kaikai Wei, Yuqing Lv, Tangfeng et al.

Source: BMC Bioinformatics. 9/29/2021, Vol. 22 Issue 1, p1-14. 14p.

Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer.

Authors: Wang, Aying Lv, Tangfeng Song, Yong

Source: Cellular Immunology. Sep2023, Vol. 391, pN.PAG-N.PAG. 1p.

Geranylgeranyl diphosphate synthase deficiency impairs efferocytosis and resolution of acute lung injury.

Authors: Jin, Jiajia Ma, Lihong Li, Lulu et al.

Source: Respiratory Research. 5/17/2025, Vol. 26 Issue 1, p1-14. 14p.

Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion.

Authors: Cheng, Qinpei Zuo, Xueying Wang, Zimu et al.

Source: Respiratory Research. 5/10/2025, Vol. 26 Issue 1, p1-20. 20p.

Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects.

Authors: Xu, Qiuli Hua, Xin Li, Bingbing et al.

Source: Cell Communication & Signaling. 2/19/2025, Vol. 23 Issue 1, p1-18. 18p.

First‐line chemoimmunotherapy for patients with small‐cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis.

Authors: Li, Yu Jiang, Yuxin Pan, Luyun et al.

Source: Thoracic Cancer. Dec2024, Vol. 15 Issue 34, p2437-2448. 12p.

MDM2 drives resistance to Osimertinib by contextually disrupting FBW7-mediated destruction of MCL-1 protein in EGFR mutant NSCLC.

Authors: Liu, Jiaxin Wei, Lingyun Miao, Qing et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 11/15/2024, Vol. 43 Issue 1, p1-17. 17p.

ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.

Authors: Hua, Xin Xu, Qiuli Wu, Ranpu et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 6/14/2024, Vol. 43 Issue 1, p1-21. 21p.

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.

Authors: Wu, Xiaodi Xu, Ke Zhan, Ping et al.

Source: BMC Infectious Diseases. 2/21/2024, Vol. 24 Issue 1, p1-12. 12p.